Collectively, these findings suggest that pharmacological NOX2 inhibitors may suppress the sepsis-associated increase in seizure susceptibility and resulting neurodegeneration by preventing microglial activation and downstream neuroinflammatory signaling. The gene discussed is CYBB; the disease is Sepsis.